• WNT5a/GSK3/β-catenin Axis Regulates FAP Adipogenesis in Musc

  2026-08-03

  This study uncovers the pivotal role of the WNT5a/GSK3/β-catenin signaling axis in controlling adipogenic differentiation of muscle-resident fibro/adipogenic progenitors (FAPs). By integrating pharmacological, single-cell, and in vivo approaches, the research identifies novel regulatory mechanisms underlying intramuscular fat accumulation, with significant implications for muscle disease intervention.

• ST3GAL1-Driven Sialylation Promotes F. nucleatum Adhesion in

  2026-08-03

  A recent study uncovers that ST3GAL1-mediated sialylation on colorectal cancer cells enhances adhesion and colonization by Fusobacterium nucleatum, implicating a novel glycan-dependent mechanism in tumor–microbe interactions. These findings refine our understanding of microbial persistence in the tumor microenvironment and open new avenues for targeting host–microbe dynamics in colorectal cancer.

• T7 RNA Polymerase in Inhalable RNA Therapeutics: Beyond Clas

  2026-08-02

  Explore how T7 RNA Polymerase—an advanced recombinant enzyme expressed in E. coli—enables next-generation in vitro transcription for inhalable RNA therapeutics and tumor microenvironment modulation. This article delivers deeper scientific insights and practical protocol guidance, setting it apart from prior workflow- or troubleshooting-focused resources.

• Asunaprevir (BMS-650032): Translational Leverage in HCV Rese

  2026-08-01

  This thought-leadership article explores the mechanistic, strategic, and translational dimensions of Asunaprevir (BMS-650032) as an advanced hepatitis C virus (HCV) NS3 protease inhibitor. We synthesize recent evidence, highlight protocol parameters, and provide actionable insights for translational researchers, while connecting lessons from epigenetic oncology. This article stands apart from standard product pages by bridging mechanistic virology, host-pathway interplay, and workflow optimization.

• Oral Faropenem Sodium: AMR Implications and Research Insight

  2026-07-31

  This article analyzes the recent literature on faropenem sodium, focusing on its broad-spectrum antimicrobial activity, oral bioavailability, and the emerging risk of antimicrobial resistance (AMR) due to overuse. The findings highlight the molecule’s clinical positioning, resistance trends, and research needs for rational application in infection models.

• iPSC-Based Drug Testing Platform Advances Cystic Fibrosis Re

  2026-07-31

  This study introduces a multimodal platform using iPSC-derived airway epithelial cells to model cystic fibrosis (CF) across diverse CFTR genotypes. The work enables precise assessment of CFTR function and drug response, supporting research into tailored therapies for rare and common CFTR mutations.

• Optimizing Inflammation and Cancer Research with LY2228820

  2026-07-30

  LY2228820, a highly selective p38 MAP kinase inhibitor, empowers researchers to dissect inflammatory and oncogenic pathways with precision. Discover stepwise workflows, advanced applications, and practical troubleshooting strategies to unlock the full potential of this compound in anti-inflammatory and cancer research.

• Strategic Advances with Norepinephrine Bitartrate in Transla

  2026-07-30

  This thought-leadership article unpacks the mechanistic and translational power of (-)-Norepinephrine (+)-bitartrate for cardiovascular research, guiding bench scientists through best practices in adrenergic signaling studies and highlighting new standards for dose reporting and model reproducibility. Drawing from recent position statements and workflow innovations, it positions APExBIO’s formulation as a pivotal tool for next-generation translational research.

• Clozapine N-oxide (CNO): Unraveling Chemogenetic Circuits in

  2026-07-29

  Explore how Clozapine N-oxide enables precise chemogenetic modulation of neural circuits implicated in Alzheimer’s and depression. This article uniquely integrates CNO’s molecular specificity with groundbreaking circuit-mapping insights, providing advanced guidance for neuroscience research.

• USP18 Controls Pyroptosis via Autophagic Degradation of Gasd

  2026-07-29

  Wang et al. (2024) reveal that USP18 limits pyroptosis by promoting selective autophagic degradation of Gasdermin D, a key executor of inflammatory cell death. This mechanistic insight advances our understanding of immune regulation and has implications for developing strategies targeting inflammatory diseases.

• Tacrolimus (FK506): Molecular Selectivity and Assay Impact i

  2026-07-28

  Explore the molecular selectivity of Tacrolimus (FK506) and its direct implications for experimental assay design in transplantation immunology research. This article provides an in-depth, evidence-based analysis that bridges mechanism with practical application for advanced immune response suppression studies.

• Calpain-Driven BDNF/TrkB Disruption Impairs Offspring Cognit

  2026-07-28

  This study demonstrates that excessive calpain activation, triggered by maternal non-obstetric surgery during pregnancy, disrupts BDNF/TrkB signaling in the developing hippocampus and impairs cognitive outcomes in offspring. The findings identify selective calpain inhibition as a potential avenue for neuroprotection and inform experimental designs investigating perinatal brain vulnerability.

• Live-Dead Cell Staining Kit: Precision Cell Viability Assays

  2026-07-27

  The Live-Dead Cell Staining Kit empowers researchers with dual-fluorescence, quantitative viability analysis for cultured cells. Its Calcein-AM and Propidium Iodide system outperforms traditional single-dye methods, making it indispensable for drug cytotoxicity, apoptosis, and advanced cell health workflows.

• Nonconventional Agonist and Antagonist Interplay at GLP-1R

  2026-07-27

  This study demonstrates that glucagon can act as an unexpected agonist at the GLP-1 receptor, with its effects counteracted by classical GLP-1 receptor antagonists. Using high-throughput FRET assays and molecular modeling, the research reveals significant cross-reactivity among peptide ligands, prompting a reevaluation of signaling specificity in metabolic and type 2 diabetes research.

• Directed Differentiation of hiPSCs to Corneal Endothelial Ce

  2026-07-26

  This study presents an efficient, chemically defined two-step protocol for differentiating human induced pluripotent stem cells (hiPSCs) into corneal endothelial-like cells by precisely modulating Wnt/β-catenin and TGF-β signaling. The approach addresses a critical gap in regenerative ophthalmology by offering a scalable alternative to donor-derived endothelial cells for cell-based therapy.

16350 records 1/1090 page Next 12345 下5页 Last page